Article

1790 views

Asthma is the most common chronic disease that affects children. At present, 235 million people suffer from asthma globally, according …

Asthma is the most common chronic disease that affects children. At present, 235 million people suffer from asthma globally, according …

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

More in INFOGRAPHICS


INFOGRAPHICS

7 Signs of ‘Depression Relapse’ that You Should Recognize Early [Infographic]

You might be familiar with the term “cancer relapse” when the cancer symptoms start showing again in the body after ...

INFOGRAPHICS

Infographics: Asthma Drug Approvals (1903-2017)

Asthma is the most common chronic disease that affects children. At present, 235 million people suffer from asthma globally, according ...

INFOGRAPHICS

Future of Cancer Treatments in India [Infographic]

While the prevalence of cancer in India is rising, Indian pharmaceutical and biotech companies are trying their best to make ...

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Seven new #healthcare #business ideas in India in 2018. Which one would you prefer to pursue?

NEWLY PUBLISHED

Pharma Patents: Can India Reward Incremental Innovation?

Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.

Leave a reply